“Effectiveness and tolerability of early initiation of combined lipid-lowering therapy included simvastatin and fenofibrate vs simvastatin alone in patients with acute coronary syndrome and type 2 diabetes mellitus with hypertriglyceridemia”, UJC, vol. 27, no. 2, pp. 34–45, Jun. 2020, doi: 10.31928/1608-635X-2020.2.3445.